MARC Record from marc_columbia

LEADER: 03774cam a2200409Ii 4500
001 11416463
005 20150720133818.0
008 150504s2015 dcua b 100 0 eng d
020 $a9780309367837
020 $a0309367832
035 $a(OCoLC)ocn908339129
035 $a(OCoLC)908339129
035 $a(NNC)11416463
040 $aAZS$beng$erda$cAZS$dNRZ$dIXA$dNTD$dYDXCP
043 $an-us---
090 $aRA650.5$b.P68 2015
100 1 $aSharples, Frances Ellen,$erapporteur.
245 10 $aPotential risks and benefits of gain-of-function research :$bsummary of a workshop /$cFrances Sharples, Jo Husbands, Anne-Marie Mazza, Audrey Thevenon, and India Hook-Barnard, Rapporteurs ; Board on Life Sciences, Division on Earth and Life Studies, Committee on Science, Technology, and Law, Policy and Global Affairs Division, Board on Health Sciences Policy, Institute of Medicine, National Research Council and Institute of Medicine of the National Academies.
264 1 $aWashington, D.C. :$bThe National Academies Press,$c[2015]
300 $axiv, 125 pages :$bcolor illustration ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 71-76).
520 $a"On October 17, 2014, spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the United States government launched a one-year deliberative process to address the continuing controversy surrounding so-called "gain-of-function" (GOF) research on respiratory pathogens with pandemic potential. The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years. The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research. Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposia on GOF research. Convened in December 2014 by the Institute of Medicine and the National Research Council, the main focus of this event was to discuss principles important for, and key considerations in, the design of risk and benefit assessments of GOF research. Participants examined the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential. This report is a record of the presentations and discussion of the meeting."--Publisher's description.
530 $aAlso issued online.
650 0 $aEpidemics$zUnited States$xPrevention$vCongresses.
700 1 $aHusbands, Jo L.,$erapporteur.
700 1 $aMazza, Anne-Marie,$erapporteur.
700 1 $aThevenon, Audrey,$erapporteur.
700 1 $aHook-Barnard, India,$erapporteur.
710 2 $aNational Research Council (U.S.).$bBoard on Life Sciences,$eissuing body.
710 2 $aNational Research Council (U.S.).$bCommittee on Science, Technology, and Law,$eissuing body.
710 2 $aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy,$eissuing body.
776 08 $aPotential Risks and Benefits of Gain-of-Function Research (Symposium) (2014 : Washington, D.C.).$tPotential risks and benefits of gain-of-function research.$dWashington, D.C. : National Academies Press, [2015]$w(OCoLC)907932833
856 41 $3National Academies Press$uhttp://www.nap.edu/openbook.php?record_id=21666
852 00 $boff,sci$hRA650.5$i.S43 2015g